The Drugs Controller General of India (DCGI) has now allowed Serum Institute of India (SII) to resume the previously paused clinical trial of the Oxford COVID-19 vaccine in the country, confirmed a sā¦
Read More
The Drugs Controller General of India (DCGI) has now allowed Serum Institute of India (SII) to resume the previously paused clinical trial of the Oxford COVID-19 vaccine in the country, confirmed a sā¦
Read More